Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology

Learn how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and the development of new treatment strategies.

[wpbb post:title]
James R. Heath, PhD, President and Professor Institute for Systems Biology, Seattle and Sean Mackay, CEO and Co-Founder, IsoPlexis
  • Learn about the technological innovations that can help you dramatically accelerate your immunotherapies and drug development.

  • Explore several case studies showing how IsoPlexis highly multiplexed bulk & single-cell capabilities enabled researchers to capture complexities connected to in vivo biology.

2021-02-18T13:59:10-05:00